Clinical trials
Transplant clinical trials
Below are recruiting transplant clinical trials, each written for real people, not researchers. We’re tracking 1,452 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07747337Recruiting
Lung transplant recovery study
This study looks at how your breathing muscles and leg muscles work before and after a lung transplant. It may help doctors understand how to improve recovery and physical function after surgery.
Gainesville, FloridaAges 18 years+ - NCT07746635Recruiting
Fecal transplant for obese women with polyendocrine ovarian syndrome
This study tests whether a fecal microbiota transplant (putting healthy bacteria from a donor into your gut) can help women with polyendocrine ovarian syndrome and obesity improve their chances of a successful frozen embryo transfer. It may help by balancing the bacteria in your gut, which could improve your overall health and fertility.
Shanghai, Shanghai MunicipalityAges 20–40 - NCT04926103Recruiting
Fecal transplant program for active ulcerative colitis donors
This trial screens people as potential donors for a fecal microbiota transplant program used for ulcerative colitis. It checks safety and eligibility so the transplant process is as safe as possible for people with active disease.
Hamilton, OntarioAges 18 years+ - NCT07739914RecruitingPhase 3
Switching anti-rejection medicine after a liver transplant
This trial tests whether switching from a standard anti-rejection medicine to a different one (everolimus) about a year after a liver transplant can help protect your new liver with fewer side effects. If you qualify, you will be monitored closely for a few years to see how well the new medicine works for you.
Heidelberg, Baden-WurttembergAges 18–80 - NCT07724873RecruitingPhase 1/Phase 2
Withaferin A to prevent GVHD after stem cell transplant
This study tests a natural compound called Withaferin A (from ashwagandha) to see if it helps prevent graft-versus-host disease (GVHD) after a stem cell transplant. The goal is to reduce the risk of transplant complications.
Navi Mumbai, MaharashtraAges 18 years+ - NCT07726134Recruiting
Diuretic use during kidney transplant to help the new kidney work faster
This trial tests whether giving a diuretic (a medication that helps flush fluids) during kidney transplant surgery helps a deceased-donor kidney start working sooner after the procedure.
London, OntarioAges 18 years+ - NCT07719946RecruitingPhase 2
Lower dose chemo after stem cell transplant for blood cancers
This trial tests whether a lower dose of the chemotherapy drug cyclophosphamide given after a stem cell transplant is safe and effective for people with blood cancers. The goal is to reduce side effects while still helping prevent the cancer from coming back.
Navi Mumbai, MaharashtraAges 18 years+ - NCT07715617Recruiting
Creating a prediction score for lung transplant or death in Alpha-1 Antitrypsin Deficiency
This study is creating a simple scoring system to predict who with Alpha-1 Antitrypsin Deficiency-related emphysema might need a lung transplant or die from the disease. Your medical records from 2010–2025 will help build this tool, with no extra tests or visits required.
BronAges 18 years+ - NCT07718204Recruiting
Medication help for kids after bone marrow transplant
This study tests a program that helps caregivers remember to give their child's oral medications after a bone marrow transplant. If you are the main caregiver for a child who had a transplant and is still in the hospital, this trial might be for you.
Columbus, OhioAges birth–12 years - NCT07709195RecruitingPhase 2
Chlorophyllin to reduce mouth sores from radiation before transplant
This trial tests whether taking chlorophyllin can reduce mouth sores caused by total body radiation given before a stem cell transplant. The goal is to make the treatment easier to tolerate.
Navi Mumbai, MaharashtraAges 12–65 - NCT07703735Enrolling by invitation
Survival after ABO-mismatch living donor liver transplant for liver cancer
This trial looks at how well patients with liver cancer do after receiving a living donor liver transplant that is not the same blood type. It compares survival and cancer return for these patients.
Ages 18 years+ - NCT07704255RecruitingPhase 4
Fecal transplant for stubborn H. pylori infection
This study tries a fecal microbiota transplant (placing healthy donor stool into your gut) to get rid of stubborn H. pylori infection that hasn't been cured by standard treatments. It's for people who have failed several rounds of therapy and have a stomach condition that makes eradication important.
Chengdu, SichuanAges 18–80 - NCT05870566Recruiting
Vitamin and light treatment before risky corneal transplant
This trial studies whether pretreatment with a specific vitamin and ultraviolet light can help a future, high-risk corneal transplant keep its new cornea healthy for longer. It may help people whose corneas already have new blood vessels, which can make transplant results harder.
München, BavariaAges 18 years+ - NCT04593589RecruitingPhase 1
Stem cell transplant to protect salivary function after oral cancer
This Phase 1 study tests whether transplanting stem cells into the submandibular gland can help restore saliva function after surgery and radiation for oral cavity squamous cell cancer. You may be considered because you recently had tumor removal and radiation aimed at the neck area, which can damage salivary glands.
GroningenAges 18 years+ - NCT07689578RecruitingPhase 4
Testing a new immunotherapy for chronic kidney transplant rejection
This study tests a new treatment called BiTE (a type of immunotherapy that helps your immune cells attack harmful antibodies) for people whose transplanted kidney is being damaged by chronic active antibody-mediated rejection. The goal is to see if it can safely slow or stop this damage.
Chengdu, SichuanAges 18 years+ - NCT07695363Recruiting
Restrictive fluids in liver transplant
This trial tests if giving less fluid during liver transplant surgery helps recovery. It is for adults with end-stage liver disease receiving a transplant.
Vancouver, British ColumbiaAges 18 years+ - NCT06533592Recruiting
Bile duct connection technique in liver transplant
This study compares two ways of connecting the bile duct during a liver transplant to see which leads to a smoother recovery. It is for adults having a planned first transplant from a deceased donor.
Warsaw, Masovian VoivodeshipAges 18–75 - NCT07673536Recruiting
Heart transplant monitoring with extracellular vesicles
This study uses tiny particles called extracellular vesicles (which cells release) to check for signs of organ rejection after a heart transplant, aiming for a safer and less invasive alternative to biopsies.
Berlin, State of BerlinAges 18 years+ - NCT07666789Recruiting
Second Islet Transplant for type 1 diabetes
This study looks at how well a second islet transplant works in people with type 1 diabetes whose first transplant stopped producing insulin or caused dangerous low blood sugar. It aims to see if getting another transplant can help control blood sugar again.
MontpellierAges 18 years+ - NCT07663669Recruiting
Photopheresis for antibody-mediated rejection in kidney transplant
This study looks at how well extracorporeal photopheresis (a treatment that filters and treats your blood with light) works for kidney transplant patients who have antibody-mediated rejection (when your immune system attacks the new kidney). It may help doctors understand if this treatment can stop the rejection.
BesançonAges 18 years+ - NCT04494776Recruiting
Study of COVID-19 in kidney transplant patients
This study looks at what happens when people with kidney transplants get COVID-19. It may help improve how doctors monitor and manage COVID-19 in transplant recipients.
São Paulo, Aão PauloAges Any age - NCT07662018Recruiting
Study of stem cell transplant after chemo for children with germ cell tumors
This study looks at how well a stem cell transplant works after a specific combination of chemotherapy drugs (gemcitabine, docetaxel, melphalan, and carboplatin) in children and young adults up to age 21 whose germ cell tumors have come back or not responded to treatment. It may help doctors understand who benefits most from this approach.
Houston, TexasAges 21 years+ - NCT07660679Recruiting
Carotid ultrasound before liver transplant surgery
This study looks at whether measuring the thickness of the carotid artery (the main artery in the neck) before a planned liver transplant can help doctors predict and manage blood flow changes during surgery. It may help patients get safer care during their transplant.
DiyarbakırAges 18 years+ - NCT06652919Recruiting
Survey on medication leaflets for transplant patients
This study asks organ transplant patients and their caregivers to evaluate medication information leaflets. Your feedback could help make these leaflets clearer and easier to understand.
Münster, North Rhine-WestphaliaAges 18 years+
Hear when a new Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplant?
- Yes. Clin2 currently lists 1,452 recruiting transplant studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplant trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplant trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.